Lucid Diagnostics Inc. (LUCD)
USD 1.5
(-0.33%)
USD 1.5
(-0.33%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -3.64 Million USD | 82.22% |
| 2022 | -20.47 Million USD | 61.84% |
| 2021 | -53.65 Million USD | -48127.94% |
| 2020 | -111.25 Thousand USD | 28.87% |
| 2019 | -156.4 Thousand USD | -778.67% |
| 2018 | -17.8 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -10.59 Million USD | -190.88% |
| 2024 Q2 | -10.68 Million USD | -0.86% |
| 2023 Q4 | -3.64 Million USD | 54.3% |
| 2023 Q3 | -7.96 Million USD | 58.35% |
| 2023 FY | -3.64 Million USD | 82.22% |
| 2023 Q1 | -25.74 Million USD | -25.74% |
| 2023 Q2 | -19.12 Million USD | 25.7% |
| 2022 Q4 | -20.47 Million USD | 17.87% |
| 2022 Q3 | -24.93 Million USD | 18.52% |
| 2022 FY | -20.47 Million USD | 61.84% |
| 2022 Q2 | -30.59 Million USD | 33.04% |
| 2022 Q1 | -45.69 Million USD | 14.84% |
| 2021 Q1 | -86.87 Thousand USD | 21.92% |
| 2021 FY | -53.65 Million USD | -48127.94% |
| 2021 Q4 | -53.65 Million USD | -100.0% |
| 2021 Q3 | 22399.99 Billion USD | 111062288.99% |
| 2021 Q2 | 20.16 Million USD | 23317.0% |
| 2020 Q4 | -111.25 Thousand USD | 0.0% |
| 2020 FY | -111.25 Thousand USD | 28.87% |
| 2019 FY | -156.4 Thousand USD | -778.67% |
| 2018 FY | -17.8 Thousand USD | 0.0% |
| 2018 Q4 | -17.8 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 113.444% |
| BrainsWay Ltd. | -10.32 Million USD | 64.719% |
| Cerus Corporation | 84.35 Million USD | 104.316% |
| Envoy Medical, Inc. | -3.81 Million USD | 4.536% |
| electroCore, Inc. | -9.95 Million USD | 63.425% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 28.956% |
| IceCure Medical Ltd | -9.93 Million USD | 63.348% |
| Inogen, Inc. | -103.56 Million USD | 96.484% |
| OrthoPediatrics Corp. | -9.26 Million USD | 60.71% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 72.2% |
| MaxCyte, Inc. | -27.76 Million USD | 86.885% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 29.137% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -532.374% |
| Orthofix Medical Inc. | 96.44 Million USD | 103.775% |
| PAVmed Inc | 29.08 Million USD | 112.518% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 78.505% |
| RxSight, Inc. | -6.68 Million USD | 45.494% |
| Sight Sciences, Inc. | -102.71 Million USD | 96.455% |
| SI-BONE, Inc. | 5.72 Million USD | 163.643% |
| TELA Bio, Inc. | -3.94 Million USD | 7.799% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 106.352% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 1134.375% |
| Acutus Medical, Inc. | 12.27 Million USD | 129.652% |
| Talis Biomedical Corporation | -57.06 Million USD | 93.619% |
| Spectral AI, Inc. | -3.5 Million USD | -3.999% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 92.419% |
| CVRx, Inc. | -59.95 Million USD | 93.927% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 283.505% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 384.979% |
| Bioventus Inc. | 372.51 Million USD | 100.977% |
| Venus Concept Inc. | 74.3 Million USD | 104.9% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 64.241% |
| LivaNova PLC | 62.53 Million USD | 105.823% |
| 908 Devices Inc. | -115.09 Million USD | 96.837% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 101.135% |
| Nemaura Medical Inc. | 9.92 Million USD | 136.685% |
| NeuroPace, Inc. | 54.33 Million USD | 106.701% |
| LENSAR, Inc. | -18.31 Million USD | 80.117% |
| Apyx Medical Corporation | -5.15 Million USD | 29.315% |
| Cutera, Inc. | 288.3 Million USD | 101.263% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 148.45% |
| BioSig Technologies, Inc. | 262 Thousand USD | 1489.695% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 91.693% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 60.42% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.259% |
| Axonics, Inc. | -77.19 Million USD | 95.283% |
| Outset Medical, Inc. | 67.67 Million USD | 105.38% |
| IRIDEX Corporation | -4.28 Million USD | 15.089% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 97.955% |
| IRadimed Corporation | -47.71 Million USD | 92.37% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -20.324% |
| INVO Bioscience, Inc. | 8.45 Million USD | 143.083% |
| Telesis Bio, Inc. | 32.63 Million USD | 111.157% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -45.516% |
| Varex Imaging Corporation | 316.9 Million USD | 101.149% |
| Quipt Home Medical Corp. | 81.73 Million USD | 104.455% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -30.877% |
| Pulmonx Corporation | -42.36 Million USD | 91.405% |
| Dynatronics Corporation | 6.2 Million USD | 158.688% |
| Modular Medical, Inc. | -8.04 Million USD | 54.725% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 15.266% |
| Semler Scientific, Inc. | -57.13 Million USD | 93.627% |
| InMode Ltd. | -135.39 Million USD | 97.311% |
| Bruker Corporation | 891.3 Million USD | 100.409% |
| Cytosorbents Corporation | 4.18 Million USD | 187.063% |
| DexCom, Inc. | 2.02 Billion USD | 100.18% |
| Align Technology, Inc. | -840.47 Million USD | 99.567% |
| Viveve Medical, Inc. | -13.81 Million USD | 73.641% |
| ZimVie Inc. | 450.41 Million USD | 100.808% |
| Movano Inc. | -5.86 Million USD | 37.93% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 97.292% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -532.374% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 283.505% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 101.02% |
| Profound Medical Corp. | -18.17 Million USD | 79.971% |
| Insulet Corporation | 798.1 Million USD | 100.456% |
| enVVeno Medical Corporation | -2.21 Million USD | -64.157% |
| Surmodics, Inc. | -12.01 Million USD | 69.694% |
| iCAD, Inc. | -21.2 Million USD | 82.833% |
| Nuwellis, Inc. | -2.81 Million USD | -29.159% |
| Biotricity, Inc. | 23.09 Million USD | 115.767% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 103.888% |
| Aethlon Medical, Inc. | -4.5 Million USD | 19.119% |
| InspireMD, Inc. | -8.04 Million USD | 54.742% |
| PAVmed Inc. | 29.08 Million USD | 112.518% |
| BIOLASE, Inc. | 11.34 Million USD | 132.096% |
| Beyond Air, Inc. | 6.22 Million USD | 158.452% |
| FONAR Corporation | -14.66 Million USD | 75.173% |
| AxoGen, Inc. | 32.26 Million USD | 111.284% |
| Vivani Medical, Inc. | 42 Thousand USD | 8769.048% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 65.838% |
| Inari Medical, Inc. | -7.16 Million USD | 49.155% |
| UFP Technologies, Inc. | 40.77 Million USD | 108.93% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 218.653% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 23.69% |
| Tenon Medical, Inc. | -1.25 Million USD | -190.12% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 52.13% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 69.471% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.164% |
| Sintx Technologies, Inc. | 905 Thousand USD | 502.32% |
| NanoVibronix, Inc. | -3.27 Million USD | -11.074% |
| Quanterix Corporation | -132.95 Million USD | 97.262% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -30.877% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 83.72% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 100.483% |
| TransMedics Group, Inc. | 121.13 Million USD | 103.006% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 86.092% |
| NeuroMetrix, Inc. | -1.49 Million USD | -144.187% |
| Hyperfine, Inc. | -75.61 Million USD | 95.185% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 102.392% |
| Biomerica, Inc. | -3.38 Million USD | -7.563% |
| Bone Biologics Corporation | -3.02 Million USD | -20.301% |
| AVITA Medical, Inc. | -26.23 Million USD | 86.12% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -98.051% |
| Silk Road Medical, Inc | 64.42 Million USD | 105.652% |